Magnetic resonance imaging in rectal cancer

A surgeon's perspective

Avanish P. Saklani, Sung Uk Bae, Amy Clayton, Namkyu Kim

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Magnetic resonance imaging (MRI) in rectal cancer was first investigated in 1999 and has become almost mandatory in planning rectal cancer treatment. MRI has a high accuracy in predicting circumferential resection margin involvement and is used to plan neoadjuvant therapy. The accuracy of MRI in assessing mesorectal lymph nodes remains moderate, as there are no reliable criteria to assess nodal involvement. MRI seems to be good in assessing peritoneal involvement in upper rectal cancer; this however has been assessed in only a few studies and needs further research. For low rectal cancers, mesorectum is thin at the level of levator ani especially in relation to prostate; so predicting circumferential resection margin involvement is not easy. However high spatial resolution coronal imaging shows levator muscles, sphincter complex and intersphincteric plane accurately. This is used to stage low rectal tumors and plan plane of surgery (standard surgery, intersphincteric resection, Extralevator abdominoperineal resection). While most centres perform MRI post chemoradiotherapy, its role in accurate staging post neoadjuvant therapy remains debatable. THe role of Diffusion weighted MRI post neoadjuvant therapy is being evaluated in research settings.

Original languageEnglish
Pages (from-to)2030-2041
Number of pages12
JournalWorld Journal of Gastroenterology
Volume20
Issue number8
DOIs
Publication statusPublished - 2014 Feb 28

Fingerprint

Rectal Neoplasms
Magnetic Resonance Imaging
Neoadjuvant Therapy
Diffusion Magnetic Resonance Imaging
Anal Canal
Chemoradiotherapy
Research
Prostate
Lymph Nodes
Surgeons
Muscles
Margins of Excision
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Saklani, Avanish P. ; Bae, Sung Uk ; Clayton, Amy ; Kim, Namkyu. / Magnetic resonance imaging in rectal cancer : A surgeon's perspective. In: World Journal of Gastroenterology. 2014 ; Vol. 20, No. 8. pp. 2030-2041.
@article{8c3a4a18381e47459867e35b25d1c3d2,
title = "Magnetic resonance imaging in rectal cancer: A surgeon's perspective",
abstract = "Magnetic resonance imaging (MRI) in rectal cancer was first investigated in 1999 and has become almost mandatory in planning rectal cancer treatment. MRI has a high accuracy in predicting circumferential resection margin involvement and is used to plan neoadjuvant therapy. The accuracy of MRI in assessing mesorectal lymph nodes remains moderate, as there are no reliable criteria to assess nodal involvement. MRI seems to be good in assessing peritoneal involvement in upper rectal cancer; this however has been assessed in only a few studies and needs further research. For low rectal cancers, mesorectum is thin at the level of levator ani especially in relation to prostate; so predicting circumferential resection margin involvement is not easy. However high spatial resolution coronal imaging shows levator muscles, sphincter complex and intersphincteric plane accurately. This is used to stage low rectal tumors and plan plane of surgery (standard surgery, intersphincteric resection, Extralevator abdominoperineal resection). While most centres perform MRI post chemoradiotherapy, its role in accurate staging post neoadjuvant therapy remains debatable. THe role of Diffusion weighted MRI post neoadjuvant therapy is being evaluated in research settings.",
author = "Saklani, {Avanish P.} and Bae, {Sung Uk} and Amy Clayton and Namkyu Kim",
year = "2014",
month = "2",
day = "28",
doi = "10.3748/wjg.v20.i8.2030",
language = "English",
volume = "20",
pages = "2030--2041",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "8",

}

Magnetic resonance imaging in rectal cancer : A surgeon's perspective. / Saklani, Avanish P.; Bae, Sung Uk; Clayton, Amy; Kim, Namkyu.

In: World Journal of Gastroenterology, Vol. 20, No. 8, 28.02.2014, p. 2030-2041.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Magnetic resonance imaging in rectal cancer

T2 - A surgeon's perspective

AU - Saklani, Avanish P.

AU - Bae, Sung Uk

AU - Clayton, Amy

AU - Kim, Namkyu

PY - 2014/2/28

Y1 - 2014/2/28

N2 - Magnetic resonance imaging (MRI) in rectal cancer was first investigated in 1999 and has become almost mandatory in planning rectal cancer treatment. MRI has a high accuracy in predicting circumferential resection margin involvement and is used to plan neoadjuvant therapy. The accuracy of MRI in assessing mesorectal lymph nodes remains moderate, as there are no reliable criteria to assess nodal involvement. MRI seems to be good in assessing peritoneal involvement in upper rectal cancer; this however has been assessed in only a few studies and needs further research. For low rectal cancers, mesorectum is thin at the level of levator ani especially in relation to prostate; so predicting circumferential resection margin involvement is not easy. However high spatial resolution coronal imaging shows levator muscles, sphincter complex and intersphincteric plane accurately. This is used to stage low rectal tumors and plan plane of surgery (standard surgery, intersphincteric resection, Extralevator abdominoperineal resection). While most centres perform MRI post chemoradiotherapy, its role in accurate staging post neoadjuvant therapy remains debatable. THe role of Diffusion weighted MRI post neoadjuvant therapy is being evaluated in research settings.

AB - Magnetic resonance imaging (MRI) in rectal cancer was first investigated in 1999 and has become almost mandatory in planning rectal cancer treatment. MRI has a high accuracy in predicting circumferential resection margin involvement and is used to plan neoadjuvant therapy. The accuracy of MRI in assessing mesorectal lymph nodes remains moderate, as there are no reliable criteria to assess nodal involvement. MRI seems to be good in assessing peritoneal involvement in upper rectal cancer; this however has been assessed in only a few studies and needs further research. For low rectal cancers, mesorectum is thin at the level of levator ani especially in relation to prostate; so predicting circumferential resection margin involvement is not easy. However high spatial resolution coronal imaging shows levator muscles, sphincter complex and intersphincteric plane accurately. This is used to stage low rectal tumors and plan plane of surgery (standard surgery, intersphincteric resection, Extralevator abdominoperineal resection). While most centres perform MRI post chemoradiotherapy, its role in accurate staging post neoadjuvant therapy remains debatable. THe role of Diffusion weighted MRI post neoadjuvant therapy is being evaluated in research settings.

UR - http://www.scopus.com/inward/record.url?scp=84894562607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894562607&partnerID=8YFLogxK

U2 - 10.3748/wjg.v20.i8.2030

DO - 10.3748/wjg.v20.i8.2030

M3 - Article

VL - 20

SP - 2030

EP - 2041

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 8

ER -